Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein

Heavy chain-binding protein (BiP) associates posttranslationally with nascent Ig heavy chains in the endoplasmic reticulum (ER) and remains associated with these heavy chains until they assemble with light chains. The heavy chain-BiP complex can be precipitated by antibody reagents against either component. To identify sites on heavy chain molecules that are important for association with BiP, we have examined 30 mouse myelomas and hybridomas that synthesize Ig heavy chains with well characterized deletions. Mutant Ig heavy chains that lack the CH1 domain could not be demonstrated to associate with BiP, whereas mutant Ig heavy chains with deletions of the CH2 or CH3 domain were still able to associate with BiP. In two light chain negative cell lines that produced heavy chains with deletions of the CH1 domain, free heavy chains were secreted. When Ig assembly and secretion were examined in mutants that did not associate with BiP, and were compared with normal parental lines, it was found that the rate of Ig secretion was increased in the mutant lines and that the Ig molecules were secreted in various stages of assembly. In one mutant line (CH1-) approximately one-third of the secreted Ig molecules were incompletely assembled, whereas the Ig molecules secreted by the parental line were completely assembled. Our data show the CH1 domain to be important for association with BiP and that when this association does not occur, incompletely assembled heavy chains can be secreted. This implies a role for BiP in preventing the transport of unassembled Ig molecules from the ER.

[1]  W. Trimble,et al.  Analysis of hybridoma mutants defective in synthesis of immunoglobulin M , 1986, Somatic cell and molecular genetics.

[2]  J. Kearney,et al.  Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas , 1986, The Journal of cell biology.

[3]  B. Thorens,et al.  Bone marrow pre‐B lymphocytes synthesize immunoglobulin mu chains of membrane type with different properties and intracellular pathways. , 1985, The EMBO journal.

[4]  M. Wabl,et al.  Immunoglobulin heavy chain binding protein , 1983, Nature.

[5]  N. Hozumi,et al.  Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants. , 1983, Nucleic acids research.

[6]  H. Lodish,et al.  Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates , 1983, Nature.

[7]  D. Kabat,et al.  Evidence for a glycoprotein "signal" involved in transport between subcellular organelles. Two membrane glycoproteins encoded by murine leukemia virus reach the cell surface at different rates. , 1982, The Journal of biological chemistry.

[8]  M. Scharff,et al.  Mutant monoclonal antibodies with alterations in biological functions , 1982, The Journal of experimental medicine.

[9]  S. Morrison,et al.  Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Zack,et al.  Somatically generated mouse myeloma variants synthesizing IgA half- molecules , 1981, The Journal of experimental medicine.

[11]  J. Brouet,et al.  Heavy Chain Diseases: Current Findings and Concepts , 1979, Immunological reviews.

[12]  P. Vassalli,et al.  Plasma cell immunoglobulin M molecules. Their biosynthesis, assembly, and intracellular transport , 1979, The Journal of cell biology.

[13]  S. Morrison Sequentially derived mutants of the constant region of the heavy chain of murine immunoglobulins. , 1979, Journal of Immunology.

[14]  Kuehl Wm,et al.  Temporal relationship of translation and glycosylation of immunoglobulin heavy and light chains. , 1978 .

[15]  S. Kornfeld,et al.  Effect of tunicamycin on IgM, IgA, and IgG secretion by mouse plasmacytoma cells. , 1978, Journal of immunology.

[16]  S. Morrison Murine heavy chain disease , 1978, European journal of immunology.

[17]  B. Dobberstein,et al.  Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma , 1975, The Journal of cell biology.

[18]  K. R. Ely,et al.  Rotational allomerism and divergent evolution of domains in immunoglobulin light chains , 1975 .

[19]  S. Morrison,et al.  Heavy chain-producing variants of a mouse myeloma cell line. , 1975, Journal of immunology.

[20]  J. Buxbaum,et al.  THE SYNTHESIS, ASSEMBLY, AND SECRETION OF GAMMA GLOBULIN BY MOUSE MYELOMA CELLS , 1973, The Journal of experimental medicine.

[21]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[22]  M. Potter,et al.  SYNTHESIS, ASSEMBLY, AND SECRETION OF GAMMA GLOBULIN BY MOUSE MYELOMA CELLS , 1970, The Journal of experimental medicine.

[23]  H. Grey,et al.  Absence of disulfide bonds linking the heavy and light chains: a property of a genetic variant of gamma-A2 globulins. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Potter,et al.  SYNTHESIS, ASSEMBLY, AND SECRETION OF GAMMA GLOBULIN BY MOUSE MYELOMA CELLS , 1971, The Journal of experimental medicine.

[25]  H. Grey,et al.  Studies on the structure of mouse gamma-A myeloma proteins. , 1968, Biochemistry.

[26]  F. Sánchez‐Madrid,et al.  Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies. , 1982, Hybridoma.

[27]  S. C. Hubbard,et al.  Synthesis and processing of asparagine-linked oligosaccharides. , 1981, Annual review of biochemistry.

[28]  M. Scharff The synthesis, assembly, and secretion of immunoglobulin: a biochemical and genetic approach. , 1973, The Harvey lectures.

[29]  H. Grey,et al.  Structure of mouse ?A myeloma proteins , 1968 .